Global Paclitaxel Market Research Report 2021 - Future Opportunities, Latest Trends, In-depth Analysis, and Forecast To 2027
ReportID: 542336
|
Published Date: 11/08/2021
|
No. of Pages: 158
|
Categories: Life Sciences
|
Format : 
The global Paclitaxel market was valued at 9.28 Million USD in 2020 and will grow with a CAGR of 8.44% from 2020 to 2027, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
Paclitaxel is a mitotic inhibitor used in Cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-funded screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark of the Pacific yew, Taxus brevifolia, and named it "taxol".In the last several years, global market of Paclitaxel developed rapidly, with an average growth rate of 12.3%. In 2017, global revenue of Paclitaxel is nearly 80 M USD; the actual production is about 2600 Kg. The classification of Paclitaxel includes Natural Paclitaxel API and Semi-Synthetic Paclitaxel API, and the proportion of Natural Paclitaxel API in 2017 is about 31.3%, and the proportion is decreasing trend from 2012 to 2017.
By Market Verdors:
Phyton
ScinoPharm
Novasep
Samyang
Polymed
TAPI (Teva)
Fresenius-kabi
Huiang biopharma
Southpharma
Yunnan Hande
Hainan Yew Pharm
Jiangsu Yew Biotechnology
By Types:
Natural Paclitaxel API
Semi-synthetic Paclitaxel API
By Applications:
Ovarian Cancer
Cervical Cancer
Breast Cancer
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
Paclitaxel is a mitotic inhibitor used in Cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-funded screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark of the Pacific yew, Taxus brevifolia, and named it "taxol".In the last several years, global market of Paclitaxel developed rapidly, with an average growth rate of 12.3%. In 2017, global revenue of Paclitaxel is nearly 80 M USD; the actual production is about 2600 Kg. The classification of Paclitaxel includes Natural Paclitaxel API and Semi-Synthetic Paclitaxel API, and the proportion of Natural Paclitaxel API in 2017 is about 31.3%, and the proportion is decreasing trend from 2012 to 2017.
By Market Verdors:
Phyton
ScinoPharm
Novasep
Samyang
Polymed
TAPI (Teva)
Fresenius-kabi
Huiang biopharma
Southpharma
Yunnan Hande
Hainan Yew Pharm
Jiangsu Yew Biotechnology
By Types:
Natural Paclitaxel API
Semi-synthetic Paclitaxel API
By Applications:
Ovarian Cancer
Cervical Cancer
Breast Cancer
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Paclitaxel Market Size Analysis from 2022 to 2027
1.5.1 Global Paclitaxel Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Paclitaxel Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Paclitaxel Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Paclitaxel Industry Impact
Chapter 2 Global Paclitaxel Competition by Types, Applications, and Top Regions and Countries
2.1 Global Paclitaxel (Volume and Value) by Type
2.1.1 Global Paclitaxel Consumption and Market Share by Type (2016-2021)
2.1.2 Global Paclitaxel Revenue and Market Share by Type (2016-2021)
2.2 Global Paclitaxel (Volume and Value) by Application
2.2.1 Global Paclitaxel Consumption and Market Share by Application (2016-2021)
2.2.2 Global Paclitaxel Revenue and Market Share by Application (2016-2021)
2.3 Global Paclitaxel (Volume and Value) by Regions
2.3.1 Global Paclitaxel Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Paclitaxel Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Paclitaxel Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Paclitaxel Consumption by Regions (2016-2021)
4.2 North America Paclitaxel Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Paclitaxel Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Paclitaxel Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Paclitaxel Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Paclitaxel Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Paclitaxel Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Paclitaxel Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Paclitaxel Sales, Consumption, Export, Import (2016-2021)
4.10 South America Paclitaxel Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Paclitaxel Market Analysis
5.1 North America Paclitaxel Consumption and Value Analysis
5.1.1 North America Paclitaxel Market Under COVID-19
5.2 North America Paclitaxel Consumption Volume by Types
5.3 North America Paclitaxel Consumption Structure by Application
5.4 North America Paclitaxel Consumption by Top Countries
5.4.1 United States Paclitaxel Consumption Volume from 2016 to 2021
5.4.2 Canada Paclitaxel Consumption Volume from 2016 to 2021
5.4.3 Mexico Paclitaxel Consumption Volume from 2016 to 2021
Chapter 6 East Asia Paclitaxel Market Analysis
6.1 East Asia Paclitaxel Consumption and Value Analysis
6.1.1 East Asia Paclitaxel Market Under COVID-19
6.2 East Asia Paclitaxel Consumption Volume by Types
6.3 East Asia Paclitaxel Consumption Structure by Application
6.4 East Asia Paclitaxel Consumption by Top Countries
6.4.1 China Paclitaxel Consumption Volume from 2016 to 2021
6.4.2 Japan Paclitaxel Consumption Volume from 2016 to 2021
6.4.3 South Korea Paclitaxel Consumption Volume from 2016 to 2021
Chapter 7 Europe Paclitaxel Market Analysis
7.1 Europe Paclitaxel Consumption and Value Analysis
7.1.1 Europe Paclitaxel Market Under COVID-19
7.2 Europe Paclitaxel Consumption Volume by Types
7.3 Europe Paclitaxel Consumption Structure by Application
7.4 Europe Paclitaxel Consumption by Top Countries
7.4.1 Germany Paclitaxel Consumption Volume from 2016 to 2021
7.4.2 UK Paclitaxel Consumption Volume from 2016 to 2021
7.4.3 France Paclitaxel Consumption Volume from 2016 to 2021
7.4.4 Italy Paclitaxel Consumption Volume from 2016 to 2021
7.4.5 Russia Paclitaxel Consumption Volume from 2016 to 2021
7.4.6 Spain Paclitaxel Consumption Volume from 2016 to 2021
7.4.7 Netherlands Paclitaxel Consumption Volume from 2016 to 2021
7.4.8 Switzerland Paclitaxel Consumption Volume from 2016 to 2021
7.4.9 Poland Paclitaxel Consumption Volume from 2016 to 2021
Chapter 8 South Asia Paclitaxel Market Analysis
8.1 South Asia Paclitaxel Consumption and Value Analysis
8.1.1 South Asia Paclitaxel Market Under COVID-19
8.2 South Asia Paclitaxel Consumption Volume by Types
8.3 South Asia Paclitaxel Consumption Structure by Application
8.4 South Asia Paclitaxel Consumption by Top Countries
8.4.1 India Paclitaxel Consumption Volume from 2016 to 2021
8.4.2 Pakistan Paclitaxel Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Paclitaxel Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Paclitaxel Market Analysis
9.1 Southeast Asia Paclitaxel Consumption and Value Analysis
9.1.1 Southeast Asia Paclitaxel Market Under COVID-19
9.2 Southeast Asia Paclitaxel Consumption Volume by Types
9.3 Southeast Asia Paclitaxel Consumption Structure by Application
9.4 Southeast Asia Paclitaxel Consumption by Top Countries
9.4.1 Indonesia Paclitaxel Consumption Volume from 2016 to 2021
9.4.2 Thailand Paclitaxel Consumption Volume from 2016 to 2021
9.4.3 Singapore Paclitaxel Consumption Volume from 2016 to 2021
9.4.4 Malaysia Paclitaxel Consumption Volume from 2016 to 2021
9.4.5 Philippines Paclitaxel Consumption Volume from 2016 to 2021
9.4.6 Vietnam Paclitaxel Consumption Volume from 2016 to 2021
9.4.7 Myanmar Paclitaxel Consumption Volume from 2016 to 2021
Chapter 10 Middle East Paclitaxel Market Analysis
10.1 Middle East Paclitaxel Consumption and Value Analysis
10.1.1 Middle East Paclitaxel Market Under COVID-19
10.2 Middle East Paclitaxel Consumption Volume by Types
10.3 Middle East Paclitaxel Consumption Structure by Application
10.4 Middle East Paclitaxel Consumption by Top Countries
10.4.1 Turkey Paclitaxel Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Paclitaxel Consumption Volume from 2016 to 2021
10.4.3 Iran Paclitaxel Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Paclitaxel Consumption Volume from 2016 to 2021
10.4.5 Israel Paclitaxel Consumption Volume from 2016 to 2021
10.4.6 Iraq Paclitaxel Consumption Volume from 2016 to 2021
10.4.7 Qatar Paclitaxel Consumption Volume from 2016 to 2021
10.4.8 Kuwait Paclitaxel Consumption Volume from 2016 to 2021
10.4.9 Oman Paclitaxel Consumption Volume from 2016 to 2021
Chapter 11 Africa Paclitaxel Market Analysis
11.1 Africa Paclitaxel Consumption and Value Analysis
11.1.1 Africa Paclitaxel Market Under COVID-19
11.2 Africa Paclitaxel Consumption Volume by Types
11.3 Africa Paclitaxel Consumption Structure by Application
11.4 Africa Paclitaxel Consumption by Top Countries
11.4.1 Nigeria Paclitaxel Consumption Volume from 2016 to 2021
11.4.2 South Africa Paclitaxel Consumption Volume from 2016 to 2021
11.4.3 Egypt Paclitaxel Consumption Volume from 2016 to 2021
11.4.4 Algeria Paclitaxel Consumption Volume from 2016 to 2021
11.4.5 Morocco Paclitaxel Consumption Volume from 2016 to 2021
Chapter 12 Oceania Paclitaxel Market Analysis
12.1 Oceania Paclitaxel Consumption and Value Analysis
12.2 Oceania Paclitaxel Consumption Volume by Types
12.3 Oceania Paclitaxel Consumption Structure by Application
12.4 Oceania Paclitaxel Consumption by Top Countries
12.4.1 Australia Paclitaxel Consumption Volume from 2016 to 2021
12.4.2 New Zealand Paclitaxel Consumption Volume from 2016 to 2021
Chapter 13 South America Paclitaxel Market Analysis
13.1 South America Paclitaxel Consumption and Value Analysis
13.1.1 South America Paclitaxel Market Under COVID-19
13.2 South America Paclitaxel Consumption Volume by Types
13.3 South America Paclitaxel Consumption Structure by Application
13.4 South America Paclitaxel Consumption Volume by Major Countries
13.4.1 Brazil Paclitaxel Consumption Volume from 2016 to 2021
13.4.2 Argentina Paclitaxel Consumption Volume from 2016 to 2021
13.4.3 Columbia Paclitaxel Consumption Volume from 2016 to 2021
13.4.4 Chile Paclitaxel Consumption Volume from 2016 to 2021
13.4.5 Venezuela Paclitaxel Consumption Volume from 2016 to 2021
13.4.6 Peru Paclitaxel Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Paclitaxel Consumption Volume from 2016 to 2021
13.4.8 Ecuador Paclitaxel Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Paclitaxel Business
14.1 Phyton
14.1.1 Phyton Company Profile
14.1.2 Phyton Paclitaxel Product Specification
14.1.3 Phyton Paclitaxel Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 ScinoPharm
14.2.1 ScinoPharm Company Profile
14.2.2 ScinoPharm Paclitaxel Product Specification
14.2.3 ScinoPharm Paclitaxel Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 Novasep
14.3.1 Novasep Company Profile
14.3.2 Novasep Paclitaxel Product Specification
14.3.3 Novasep Paclitaxel Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 Samyang
14.4.1 Samyang Company Profile
14.4.2 Samyang Paclitaxel Product Specification
14.4.3 Samyang Paclitaxel Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 Polymed
14.5.1 Polymed Company Profile
14.5.2 Polymed Paclitaxel Product Specification
14.5.3 Polymed Paclitaxel Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 TAPI (Teva)
14.6.1 TAPI (Teva) Company Profile
14.6.2 TAPI (Teva) Paclitaxel Product Specification
14.6.3 TAPI (Teva) Paclitaxel Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.7 Fresenius-kabi
14.7.1 Fresenius-kabi Company Profile
14.7.2 Fresenius-kabi Paclitaxel Product Specification
14.7.3 Fresenius-kabi Paclitaxel Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.8 Huiang biopharma
14.8.1 Huiang biopharma Company Profile
14.8.2 Huiang biopharma Paclitaxel Product Specification
14.8.3 Huiang biopharma Paclitaxel Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.9 Southpharma
14.9.1 Southpharma Company Profile
14.9.2 Southpharma Paclitaxel Product Specification
14.9.3 Southpharma Paclitaxel Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.10 Yunnan Hande
14.10.1 Yunnan Hande Company Profile
14.10.2 Yunnan Hande Paclitaxel Product Specification
14.10.3 Yunnan Hande Paclitaxel Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.11 Hainan Yew Pharm
14.11.1 Hainan Yew Pharm Company Profile
14.11.2 Hainan Yew Pharm Paclitaxel Product Specification
14.11.3 Hainan Yew Pharm Paclitaxel Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.12 Jiangsu Yew Biotechnology
14.12.1 Jiangsu Yew Biotechnology Company Profile
14.12.2 Jiangsu Yew Biotechnology Paclitaxel Product Specification
14.12.3 Jiangsu Yew Biotechnology Paclitaxel Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Paclitaxel Market Forecast (2022-2027)
15.1 Global Paclitaxel Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Paclitaxel Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Paclitaxel Value and Growth Rate Forecast (2022-2027)
15.2 Global Paclitaxel Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Paclitaxel Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Paclitaxel Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Paclitaxel Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Paclitaxel Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Paclitaxel Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Paclitaxel Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Paclitaxel Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Paclitaxel Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Paclitaxel Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Paclitaxel Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Paclitaxel Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Paclitaxel Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Paclitaxel Consumption Forecast by Type (2022-2027)
15.3.2 Global Paclitaxel Revenue Forecast by Type (2022-2027)
15.3.3 Global Paclitaxel Price Forecast by Type (2022-2027)
15.4 Global Paclitaxel Consumption Volume Forecast by Application (2022-2027)
15.5 Paclitaxel Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Paclitaxel Market Size Analysis from 2022 to 2027
1.5.1 Global Paclitaxel Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Paclitaxel Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Paclitaxel Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Paclitaxel Industry Impact
Chapter 2 Global Paclitaxel Competition by Types, Applications, and Top Regions and Countries
2.1 Global Paclitaxel (Volume and Value) by Type
2.1.1 Global Paclitaxel Consumption and Market Share by Type (2016-2021)
2.1.2 Global Paclitaxel Revenue and Market Share by Type (2016-2021)
2.2 Global Paclitaxel (Volume and Value) by Application
2.2.1 Global Paclitaxel Consumption and Market Share by Application (2016-2021)
2.2.2 Global Paclitaxel Revenue and Market Share by Application (2016-2021)
2.3 Global Paclitaxel (Volume and Value) by Regions
2.3.1 Global Paclitaxel Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Paclitaxel Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Paclitaxel Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Paclitaxel Consumption by Regions (2016-2021)
4.2 North America Paclitaxel Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Paclitaxel Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Paclitaxel Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Paclitaxel Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Paclitaxel Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Paclitaxel Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Paclitaxel Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Paclitaxel Sales, Consumption, Export, Import (2016-2021)
4.10 South America Paclitaxel Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Paclitaxel Market Analysis
5.1 North America Paclitaxel Consumption and Value Analysis
5.1.1 North America Paclitaxel Market Under COVID-19
5.2 North America Paclitaxel Consumption Volume by Types
5.3 North America Paclitaxel Consumption Structure by Application
5.4 North America Paclitaxel Consumption by Top Countries
5.4.1 United States Paclitaxel Consumption Volume from 2016 to 2021
5.4.2 Canada Paclitaxel Consumption Volume from 2016 to 2021
5.4.3 Mexico Paclitaxel Consumption Volume from 2016 to 2021
Chapter 6 East Asia Paclitaxel Market Analysis
6.1 East Asia Paclitaxel Consumption and Value Analysis
6.1.1 East Asia Paclitaxel Market Under COVID-19
6.2 East Asia Paclitaxel Consumption Volume by Types
6.3 East Asia Paclitaxel Consumption Structure by Application
6.4 East Asia Paclitaxel Consumption by Top Countries
6.4.1 China Paclitaxel Consumption Volume from 2016 to 2021
6.4.2 Japan Paclitaxel Consumption Volume from 2016 to 2021
6.4.3 South Korea Paclitaxel Consumption Volume from 2016 to 2021
Chapter 7 Europe Paclitaxel Market Analysis
7.1 Europe Paclitaxel Consumption and Value Analysis
7.1.1 Europe Paclitaxel Market Under COVID-19
7.2 Europe Paclitaxel Consumption Volume by Types
7.3 Europe Paclitaxel Consumption Structure by Application
7.4 Europe Paclitaxel Consumption by Top Countries
7.4.1 Germany Paclitaxel Consumption Volume from 2016 to 2021
7.4.2 UK Paclitaxel Consumption Volume from 2016 to 2021
7.4.3 France Paclitaxel Consumption Volume from 2016 to 2021
7.4.4 Italy Paclitaxel Consumption Volume from 2016 to 2021
7.4.5 Russia Paclitaxel Consumption Volume from 2016 to 2021
7.4.6 Spain Paclitaxel Consumption Volume from 2016 to 2021
7.4.7 Netherlands Paclitaxel Consumption Volume from 2016 to 2021
7.4.8 Switzerland Paclitaxel Consumption Volume from 2016 to 2021
7.4.9 Poland Paclitaxel Consumption Volume from 2016 to 2021
Chapter 8 South Asia Paclitaxel Market Analysis
8.1 South Asia Paclitaxel Consumption and Value Analysis
8.1.1 South Asia Paclitaxel Market Under COVID-19
8.2 South Asia Paclitaxel Consumption Volume by Types
8.3 South Asia Paclitaxel Consumption Structure by Application
8.4 South Asia Paclitaxel Consumption by Top Countries
8.4.1 India Paclitaxel Consumption Volume from 2016 to 2021
8.4.2 Pakistan Paclitaxel Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Paclitaxel Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Paclitaxel Market Analysis
9.1 Southeast Asia Paclitaxel Consumption and Value Analysis
9.1.1 Southeast Asia Paclitaxel Market Under COVID-19
9.2 Southeast Asia Paclitaxel Consumption Volume by Types
9.3 Southeast Asia Paclitaxel Consumption Structure by Application
9.4 Southeast Asia Paclitaxel Consumption by Top Countries
9.4.1 Indonesia Paclitaxel Consumption Volume from 2016 to 2021
9.4.2 Thailand Paclitaxel Consumption Volume from 2016 to 2021
9.4.3 Singapore Paclitaxel Consumption Volume from 2016 to 2021
9.4.4 Malaysia Paclitaxel Consumption Volume from 2016 to 2021
9.4.5 Philippines Paclitaxel Consumption Volume from 2016 to 2021
9.4.6 Vietnam Paclitaxel Consumption Volume from 2016 to 2021
9.4.7 Myanmar Paclitaxel Consumption Volume from 2016 to 2021
Chapter 10 Middle East Paclitaxel Market Analysis
10.1 Middle East Paclitaxel Consumption and Value Analysis
10.1.1 Middle East Paclitaxel Market Under COVID-19
10.2 Middle East Paclitaxel Consumption Volume by Types
10.3 Middle East Paclitaxel Consumption Structure by Application
10.4 Middle East Paclitaxel Consumption by Top Countries
10.4.1 Turkey Paclitaxel Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Paclitaxel Consumption Volume from 2016 to 2021
10.4.3 Iran Paclitaxel Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Paclitaxel Consumption Volume from 2016 to 2021
10.4.5 Israel Paclitaxel Consumption Volume from 2016 to 2021
10.4.6 Iraq Paclitaxel Consumption Volume from 2016 to 2021
10.4.7 Qatar Paclitaxel Consumption Volume from 2016 to 2021
10.4.8 Kuwait Paclitaxel Consumption Volume from 2016 to 2021
10.4.9 Oman Paclitaxel Consumption Volume from 2016 to 2021
Chapter 11 Africa Paclitaxel Market Analysis
11.1 Africa Paclitaxel Consumption and Value Analysis
11.1.1 Africa Paclitaxel Market Under COVID-19
11.2 Africa Paclitaxel Consumption Volume by Types
11.3 Africa Paclitaxel Consumption Structure by Application
11.4 Africa Paclitaxel Consumption by Top Countries
11.4.1 Nigeria Paclitaxel Consumption Volume from 2016 to 2021
11.4.2 South Africa Paclitaxel Consumption Volume from 2016 to 2021
11.4.3 Egypt Paclitaxel Consumption Volume from 2016 to 2021
11.4.4 Algeria Paclitaxel Consumption Volume from 2016 to 2021
11.4.5 Morocco Paclitaxel Consumption Volume from 2016 to 2021
Chapter 12 Oceania Paclitaxel Market Analysis
12.1 Oceania Paclitaxel Consumption and Value Analysis
12.2 Oceania Paclitaxel Consumption Volume by Types
12.3 Oceania Paclitaxel Consumption Structure by Application
12.4 Oceania Paclitaxel Consumption by Top Countries
12.4.1 Australia Paclitaxel Consumption Volume from 2016 to 2021
12.4.2 New Zealand Paclitaxel Consumption Volume from 2016 to 2021
Chapter 13 South America Paclitaxel Market Analysis
13.1 South America Paclitaxel Consumption and Value Analysis
13.1.1 South America Paclitaxel Market Under COVID-19
13.2 South America Paclitaxel Consumption Volume by Types
13.3 South America Paclitaxel Consumption Structure by Application
13.4 South America Paclitaxel Consumption Volume by Major Countries
13.4.1 Brazil Paclitaxel Consumption Volume from 2016 to 2021
13.4.2 Argentina Paclitaxel Consumption Volume from 2016 to 2021
13.4.3 Columbia Paclitaxel Consumption Volume from 2016 to 2021
13.4.4 Chile Paclitaxel Consumption Volume from 2016 to 2021
13.4.5 Venezuela Paclitaxel Consumption Volume from 2016 to 2021
13.4.6 Peru Paclitaxel Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Paclitaxel Consumption Volume from 2016 to 2021
13.4.8 Ecuador Paclitaxel Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Paclitaxel Business
14.1 Phyton
14.1.1 Phyton Company Profile
14.1.2 Phyton Paclitaxel Product Specification
14.1.3 Phyton Paclitaxel Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 ScinoPharm
14.2.1 ScinoPharm Company Profile
14.2.2 ScinoPharm Paclitaxel Product Specification
14.2.3 ScinoPharm Paclitaxel Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 Novasep
14.3.1 Novasep Company Profile
14.3.2 Novasep Paclitaxel Product Specification
14.3.3 Novasep Paclitaxel Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 Samyang
14.4.1 Samyang Company Profile
14.4.2 Samyang Paclitaxel Product Specification
14.4.3 Samyang Paclitaxel Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 Polymed
14.5.1 Polymed Company Profile
14.5.2 Polymed Paclitaxel Product Specification
14.5.3 Polymed Paclitaxel Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 TAPI (Teva)
14.6.1 TAPI (Teva) Company Profile
14.6.2 TAPI (Teva) Paclitaxel Product Specification
14.6.3 TAPI (Teva) Paclitaxel Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.7 Fresenius-kabi
14.7.1 Fresenius-kabi Company Profile
14.7.2 Fresenius-kabi Paclitaxel Product Specification
14.7.3 Fresenius-kabi Paclitaxel Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.8 Huiang biopharma
14.8.1 Huiang biopharma Company Profile
14.8.2 Huiang biopharma Paclitaxel Product Specification
14.8.3 Huiang biopharma Paclitaxel Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.9 Southpharma
14.9.1 Southpharma Company Profile
14.9.2 Southpharma Paclitaxel Product Specification
14.9.3 Southpharma Paclitaxel Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.10 Yunnan Hande
14.10.1 Yunnan Hande Company Profile
14.10.2 Yunnan Hande Paclitaxel Product Specification
14.10.3 Yunnan Hande Paclitaxel Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.11 Hainan Yew Pharm
14.11.1 Hainan Yew Pharm Company Profile
14.11.2 Hainan Yew Pharm Paclitaxel Product Specification
14.11.3 Hainan Yew Pharm Paclitaxel Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.12 Jiangsu Yew Biotechnology
14.12.1 Jiangsu Yew Biotechnology Company Profile
14.12.2 Jiangsu Yew Biotechnology Paclitaxel Product Specification
14.12.3 Jiangsu Yew Biotechnology Paclitaxel Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Paclitaxel Market Forecast (2022-2027)
15.1 Global Paclitaxel Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Paclitaxel Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Paclitaxel Value and Growth Rate Forecast (2022-2027)
15.2 Global Paclitaxel Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Paclitaxel Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Paclitaxel Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Paclitaxel Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Paclitaxel Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Paclitaxel Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Paclitaxel Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Paclitaxel Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Paclitaxel Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Paclitaxel Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Paclitaxel Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Paclitaxel Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Paclitaxel Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Paclitaxel Consumption Forecast by Type (2022-2027)
15.3.2 Global Paclitaxel Revenue Forecast by Type (2022-2027)
15.3.3 Global Paclitaxel Price Forecast by Type (2022-2027)
15.4 Global Paclitaxel Consumption Volume Forecast by Application (2022-2027)
15.5 Paclitaxel Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
Published On:11/08/2021
Base Year:
Historical Data:
No of Pages:158
Price
Global Paclitaxel Market Research Report 2021 - Future Opportunities, Latest Trends, In-depth Analysis, and Forecast To 2027
A2Z Market Research is one of the leading providers of market intelligence products and services. We offer reports on over 10+ industries and update our collection daily which helps our clients to access database of expert market insights on global industries, companies, products, and trends.
Subscribe Us
Sign up today for tips and latest news
and exclusive special offers.
